Skip to main content
. 2022 Feb 26;27(3):e223–e232. doi: 10.1093/oncolo/oyac001

Figure 2.

Figure 2.

Enfortumab vedotin proposed mechanism of action.7,26aAdditional mechanisms of action and their potential to complement the direct cytotoxicity of enfortumab vedotin are unknown.